Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24846753 | 1.00 | FKBP1A (0.55) | FKBP1AALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL13601738 | 0.95 | FKBP1A (0.49) | FKBP1AALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL11490823 | 0.95 | FKBP1A (0.49) | FKBP1AALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL11490824 | 0.95 | FKBP1A (0.49) | FKBP1AALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL26039280 | 0.86 | FKBP1A (0.43) | FKBP1AALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL9246148 | 0.81 | CHRNB2 (0.50) | — | |
| SCHEMBL24131501 | 0.81 | RAB9A (0.50) | FKBP1AALDH1A1TSHR | |
| SCHEMBL9246142 | 0.81 | FKBP1A (0.42) | FKBP1AMEN1KMT2A | |
| SCHEMBL19576693 | 0.81 | FKBP1A (0.51) | FKBP1AALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL6782112 | 0.81 | KDM4E (0.56) | FKBP1AALDH1A1KDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023189433-A1 | ULTRAVIOLET RADIATION-CURABLE POLYSILOXANE COMPOSITION, AND DAMPING MATERIAL | 株式会社タイカ | 2023-10-05 | — | — | WO | disclosed |
| US-20230192620-A1 | ANILINE COMPOUND USED AS RORy REGULATOR | SHANGHAI LITEDD CO., LTD. (CN) | 2023-06-22 | — | — | US | disclosed |
| WO-2021072140-A1 | PRODRUGS OF MYELOPEROXIDASE INHIBITORS | BIOHAVEN THERAPEUTICS LTD. (US) | 2021-04-15 | — | — | WO | disclosed |
| CN-109912570-A | A kind of preparation method of argatroban intermediate amidate | 天津药物研究院药业有限责任公司 | 2019-06-21 | — | — | CN | disclosed |
| US-9709907-B2 | Electrophotographic photosensitive member, process cartridge and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2017-07-18 | — | — | US | disclosed |
| US-9709907-B2 | Electrophotographic photosensitive member, process cartridge and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2017-07-18 | — | — | US | disclosed |
| US-9500966-B2 | Electrophotographic photosensitive member, process cartridge and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2016-11-22 | — | — | US | disclosed |
| US-9500966-B2 | Electrophotographic photosensitive member, process cartridge and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2016-11-22 | — | — | US | disclosed |
| US-9340505-B2 | Type III secretion inhibitors, analogs and uses thereof | UNIVERSITY OF MASSACHUSETTS (US) | 2016-05-17 | — | — | US | disclosed |
| US-20150362848-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE AND ELECTROPHOTOGRAPHIC APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2015-12-17 | — | — | US | disclosed |
| US-20030153505-A1 | Dolastatin 15 derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2003-08-14 | — | — | US | disclosed |
| US-6458765-B1 | POLYPEPTIDES AS ANTICANCER AGENTS AND AGAINST CELL PROLIFERATION | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-01 | — | — | US | disclosed |
| US-20010034419-A1 | Radiation transparent molding materials | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2001-10-25 | — | — | US | disclosed |
| US-6143721-A | FOR TREATING CANCER IN MAMMALS | BASF AKTIENGESELLSCHAFT (DE) | 2000-11-07 | — | — | US | disclosed |
| EP-0991658-A1 | DOLASTATIN 15 DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2000-04-12 | — | — | EP | disclosed |
| WO-1999003879-A1 | DOLASTATIN 15 DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-28 | — | — | WO | disclosed |
| EP-0527427-B1 | Catalysts and casting article, method, and composition | MINNESOTA MINING & MFG (US) | 1995-11-15 | — | — | EP | disclosed |
| US-5225513-A | Orthopedic casting | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-07-06 | — | — | US | disclosed |
| EP-0527427-A2 | Catalysts and casting article, method, and composition | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-02-17 | — | — | EP | disclosed |
| US-4190579-A | Synthesis of beta-lactams from azetidine carboxylic acid esters | RESEARCH CORPORATION (US) | 1980-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192620-A1 | ANILINE COMPOUND USED AS RORy REGULATOR | RORB, RORA, RORC | FKBP1A 155/4885ALDH1A1 536/4885KDM4E 1923/4885 |
| US-20030153505-A1 | Dolastatin 15 derivatives | DBI, DDOST, BDKRB1 | FKBP1A 2559/4885ALDH1A1 1840/4885KDM4E 2445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.